Sun Pharmaceutical Industries has successfully won a U.S. antitrust appeal involving a settlement related to the cholesterol medication Lipitor, according to legal developments noted in the market.
Further details concerning the specific court ruling and the financial or operational implications of the decision were not immediately available following the announcement.
